NCT00674856View on ClinicalTrials.gov

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions
Renal Failure
Interventions
DRUG

naproxcinod

750mg

Trial Locations (3)

Unknown

Orlando

Minneapolis

Saint Paul

Sponsors

Lead Sponsor

NicOx
All Listed Sponsors
lead

NicOx

INDUSTRY